beta4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization

Biochem Biophys Res Commun. 2007 Jun 22;358(1):41-6. doi: 10.1016/j.bbrc.2007.04.044. Epub 2007 Apr 18.

Abstract

beta1,4-Galactosyltransferase II (beta4GalT-II) is one of the enzymes transferring galactose to the terminal N-acetylglucosamine of complex-type N-glycans and its expression is significantly altered during oncogenesis with unknown functions. Here, we reported for the first time the pro-apoptotic role of beta4GalT-II in tumor cells. The level of beta4GalT-II mRNA expression was obviously decreased during HeLa cell apoptosis induced by cisplatin. Interestingly, the ectopic expression of beta4GalT-II in HeLa cells markedly increased apoptosis and cleavage of PARP induced by cisplatin as well as the expression of pro-apoptotic protein Bax. Furthermore, deletion of Golgi localization domain abolished the apoptotic role of beta4GalT-II in HeLa cells. Collectively, these results suggest that beta4GalT-II increases HeLa cell apoptosis induced by cisplatin depending on its Golgi localization, which indicates that beta4GalT-II might contribute to the therapeutic efficiency of cisplatin for cervix cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Cisplatin / pharmacology*
  • Collagen Type XI / metabolism
  • Galactosyltransferases / biosynthesis
  • Galactosyltransferases / genetics
  • Galactosyltransferases / metabolism*
  • Golgi Apparatus / drug effects
  • Golgi Apparatus / enzymology*
  • HeLa Cells
  • Humans
  • Mutation
  • RNA, Messenger / biosynthesis
  • bcl-2-Associated X Protein / metabolism

Substances

  • Antineoplastic Agents
  • COL11A2 protein, human
  • Collagen Type XI
  • RNA, Messenger
  • bcl-2-Associated X Protein
  • Galactosyltransferases
  • beta-1,4-galactosyltransferase II
  • Cisplatin